Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone
Open Access
- 1 December 1988
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 32 (12) , 1896-1898
- https://doi.org/10.1128/aac.32.12.1896
Abstract
Cefpodoxime, cefixime, and ceftriaxone inhibited Branhamella catarrhalis at less than or equal to 1 microgram/ml, beta-hemolytic streptococci at less than or equal to 0.25 microgram/ml, Neisseria meningitidis at less than or equal to 0.06 microgram/ml, and Haemophilus influenzae (other than beta-lactamase-negative, ampicillin-resistant isolates) at less than or equal to 0.12 microgram/ml. The MICs for 50% of isolates of the family Enterobacteriaceae other than Citrobacter freundii, Enterobacter aerogenes, and Enterobacter cloacae were less than or equal to 1 microgram/ml for all three cephalosporins. The MICs of each cephalosporin for 90% of staphylococci, enterococci, and Pseudomonas aeruginosa isolates were greater than 16 micrograms/ml. Inoculum effects were noted with cefpodoxime and cefixime with beta-lactamase-positive H. influenzae.This publication has 5 references indexed in Scilit:
- In vitro activity of U-76,252 (CS-807), a new oral cephalosporinAntimicrobial Agents and Chemotherapy, 1988
- Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807)Antimicrobial Agents and Chemotherapy, 1988
- In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporinAntimicrobial Agents and Chemotherapy, 1987
- Studies on orally active cephalosporin esters.The Journal of Antibiotics, 1987
- MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniquesAntimicrobial Agents and Chemotherapy, 1984